Maharashtra registers 5,609 COVID-19 cases, 137 deaths

Maharashtra's case recovery rate now stands at 96.8 percent and the fatality rate is 2.01 percent.

PTI

August 10, 2021 / 21:18 IST

PTI

Maharashtra on Tuesday reported 5,609 coronavirus positive cases and 137 fatalities, including the highest 46 in the Pune region, while 7,568 patients recovered, a state health department official said.

With the new additions, the tally of infections and the death toll in Maharashtra rose to 63,63,442 and 1,34,201, respectively, the official said.

The number of recoveries has increased to 61,59,676, leaving the state with 66,123 active cases. Compared to Monday, the number of cases went up by 1,104 in Maharashtra while the count of fatalities doubled compared to 68 deaths reported the day before.

Maharashtra's case recovery rate now stands at 96.8 percent and the fatality rate is 2.01 percent.

Dhule, Nandurbar, Washim, Wardha, Bhandara and Gondia districts, and Malegaon and Parbhani municipal corporations did not report any new COVID-19 case, the official said. At 782, Satara district reported the highest number of new infections in the state in the day.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show